Zim Laboratories Limited — Others, 28-03-2025: Change in Management

Zim Laboratories Limited has announced a board meeting approving key changes in its corporate governance. Mr. Ashok Bhatia has been appointed as an Independent Director, effective from 1st April 2025, bringing extensive pharmaceutical experience from his previous roles. Dr. Kamesh Shende has been re-appointed as an Independent Director for another term beginning the same date. Meanwhile, Dr. Kakasaheb Mahadik will complete his tenure, and Mr. Pradeep Katariya, Senior Vice President of Operations, will voluntarily retire, ceasing his role as well. These adjustments are pending approval at the General Meeting. Overall, this reshuffle aims to strengthen the board's capabilities, potentially enhancing investor confidence and reflecting a proactive approach to leadership.